TRPC6
TRPC6 (transient receptor potential cation channel subfamily C member 6, also TRP6 or FSGS2) is a non-selective, calcium-permeable cation channel in the cell membrane. It is activated by diacylglycerol and mediates calcium entry downstream of G(q)-coupled receptor and receptor tyrosine kinase signalling. Browse Assay Genie's current range of TRPC6 research reagents below, or read on for the biology behind the target.
TRPC6 forms a receptor-activated, non-selective cation channel that is permeable to calcium. Channel opening follows activation of G(q)-coupled receptors or receptor tyrosine kinases, which triggers phospholipase C (PLC)-mediated hydrolysis of phosphatidylinositides. The resulting diacylglycerol (DAG) directly activates TRPC6. Activation occurs independently of protein kinase C and does not appear to depend on depletion of intracellular calcium stores, and low levels of intracellular calcium do not trigger it. The channel is thought to be under the control of a phosphatidylinositol second messenger system.
In intrinsically photosensitive retinal ganglion cells (ipRGCs), TRPC6 contributes to depolarisation in response to light-induced, melanopsin (OPN4)-mediated phototransduction through G(q)-PLC signalling. This is likely achieved through heteromeric TRPC6-TRPC7 channels. Researchers studying the TRPC6 protein therefore often work on calcium signalling, phospholipase C pathways and sensory transduction.
The TRPC6 gene belongs to the transient receptor potential family (TC 1.A.4), in the STrpC subfamily and TRPC6 sub-subfamily. HGNC places it in the ankyrin repeat domain containing group, the transient receptor potential cation channel subfamily C group, and among microRNA protein coding host genes. The mouse ortholog is Trpc6. The previous gene name, focal segmental glomerulosclerosis 2, reflects the disease association: defects in the TRPC6 gene are a cause of focal segmental glomerulosclerosis 2 (FSGS2). Together with the TRPC6 antibody and TRPC6 ELISA kit formats used in the field, this makes the channel a frequent subject in renal and calcium signalling research.
TRPC6 mediates calcium entry after G(q)-coupled receptor or receptor tyrosine kinase activation, making it a model for receptor-operated channels.
Defects in the TRPC6 gene cause focal segmental glomerulosclerosis 2 (FSGS2), which links the channel to glomerular disease.
TRPC6, likely as TRPC6-TRPC7 heteromers, helps depolarise ipRGCs during melanopsin-mediated, G(q)-PLC light signalling.
Direct activation by diacylglycerol, independent of protein kinase C, makes TRPC6 useful for studying PLC-driven phosphatidylinositide signalling.
TRPC6 is a non-selective, calcium-permeable cation channel in the cell membrane. It opens when diacylglycerol is produced after G(q)-coupled receptor or receptor tyrosine kinase activation of phospholipase C, allowing calcium entry. It does not appear to respond to depletion of intracellular calcium stores.
TRPC6 is also written TRP6 or FSGS2. The full HGNC name is transient receptor potential cation channel subfamily C member 6, and UniProt lists it as short transient receptor potential channel 6. The earlier name, focal segmental glomerulosclerosis 2, reflects its disease link.
Defects in the TRPC6 gene are a cause of focal segmental glomerulosclerosis 2 (FSGS2). The mouse ortholog is Trpc6, so rodent models can be used to study the channel. Check the datasheet of any product for its validated reactivity.
Other TRPC family members and associated proteins with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9Y210; product specifications from Assay Genie datasheets.